Sfoglia per Rivista JAMA NEUROLOGY
Recurrent Stroke with Rivaroxaban Compared with Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial
2019 Healey, J. S.; Gladstone, D. J.; Swaminathan, B.; Eckstein, J.; Mundl, H.; Epstein, A. E.; Haeusler, K. G.; Mikulik, R.; Kasner, S. E.; Toni, D.; Arauz, A.; Ntaios, G.; Hankey, G. J.; Perera, K.; Pagola, J.; Shuaib, A.; Lutsep, H.; Yang, X.; Uchiyama, S.; Endres, M.; Coutts, S. B.; Karlinski, M.; Czlonkowska, A.; Molina, C. A.; Santo, G.; Berkowitz, S. D.; Hart, R. G.; Connolly, S. J.
Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study
2013 N., Ahmed; L., Kellert; K. r., Lees; R., Mikulik; T., Tatlisumak; Toni, Danilo; For The Sits, Investigators
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
2020 Amarenco, P.; Denison, H.; Evans, S. R.; Himmelmann, A.; James, S.; Knutsson, M.; Ladenvall, P.; Molina, C. A.; Wang, Y.; Johnston, S. C.; Toni, D.
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
2013 Provenzano, Fa; Muraskin, J; Tosto, Giuseppe; Narkhede, A; Wasserman, Bt; Griffith, Ey; Guzman, Va; Meier, Ib; Zimmerman, Me; Brickman, Am
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Recurrent Stroke with Rivaroxaban Compared with Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial | 2019 | Healey, J. S.; Gladstone, D. J.; Swaminathan, B.; Eckstein, J.; Mundl, H.; Epstein, A. E.; Haeusler, K. G.; Mikulik, R.; Kasner, S. E.; Toni, D.; Arauz, A.; Ntaios, G.; Hankey, G. J.; Perera, K.; Pagola, J.; Shuaib, A.; Lutsep, H.; Yang, X.; Uchiyama, S.; Endres, M.; Coutts, S. B.; Karlinski, M.; Czlonkowska, A.; Molina, C. A.; Santo, G.; Berkowitz, S. D.; Hart, R. G.; Connolly, S. J. | |
Results of Intravenous Thrombolysis Within 4.5 to 6 Hours and Updated Results Within 3 to 4.5 Hours of Onset of Acute Ischemic Stroke Recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR) An Observational Study | 2013 | N., Ahmed; L., Kellert; K. r., Lees; R., Mikulik; T., Tatlisumak; Toni, Danilo; For The Sits, Investigators | |
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial | 2020 | Amarenco, P.; Denison, H.; Evans, S. R.; Himmelmann, A.; James, S.; Knutsson, M.; Ladenvall, P.; Molina, C. A.; Wang, Y.; Johnston, S. C.; Toni, D. | |
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? | 2013 | Provenzano, Fa; Muraskin, J; Tosto, Giuseppe; Narkhede, A; Wasserman, Bt; Griffith, Ey; Guzman, Va; Meier, Ib; Zimmerman, Me; Brickman, Am |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile